Estados Unidos · Bolsa y Finanzas · MarketWatch

Alvotech Shares Rise After FDA Approves Additional Manufacturing for Simlandi

Publicado por MarketWatch · Estados Unidos hace 12 h

Alvotech shares rose after the company said the Food and Drug Administration has approved a supplement to the biologics license application for AVT02 adalimumab-ryvk, marketed in…

Leer el artículo completo en MarketWatch Inicie sesión para guardar

MediaNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.marketwatch.com)

Alvotech Shares Rise After FDA Approves Additional Manufacturing for Simlandi

También te puede interesar

AstraZeneca CEO Soriot says drugmaker can grow without big acquisition

Texas businessman gets 13 years in federal prison as feds seize his Lamborghinis, Ferraris, Firebird and dozens more cars to pay back fraud victims

These are the longest rivers on every continent

Singapore Eyes Nuclear Power as Iran War Exposes Its Import Problem

FinCEN withdraws proposed crypto mixing rule over ‘legitimate activity’ concerns

OpenAI will start watermarking ChatGPT’s text in the EU

Alvotech Shares Rise After FDA Approves Additional Manufacturing for Simlandi

Compartir

También te puede interesar

AstraZeneca CEO Soriot says drugmaker can grow without big acquisition

Texas businessman gets 13 years in federal prison as feds seize his Lamborghinis, Ferraris, Firebird and dozens more cars to pay back fraud victims

These are the longest rivers on every continent

Singapore Eyes Nuclear Power as Iran War Exposes Its Import Problem

FinCEN withdraws proposed crypto mixing rule over ‘legitimate activity’ concerns

OpenAI will start watermarking ChatGPT’s text in the EU